ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Boy with rare disease gets new skin with gene therapy – Sumter Item

Sumter ItemBoy with rare disease gets new skin with gene therapySumter ItemLONDON – Doctors treating a critically ill boy with a devastating skin disease used experimental gene therapy to create an entirely new skin for most of his body in a desperate … Continue reading

2017-11-10 Michael Zand NEWS

NPL, Imperial College London launch new virtual lab – PharmaTimes

Continue reading

2017-11-10 Michael Zand NEWS

Innovative biology – Texas A&M The Battalion


PharmaTimes

NPL, Imperial College London launch new virtual lab
PharmaTimes
NPL and Imperial College London have unveiled a new £7 million virtual lab to help the UK’s synthetic biology industry enhance the manufacturing and adoption of new drugs, therapies and other products. The new lab, part of £17 million of new government …

Continue reading

2017-11-10 Michael Zand NEWS

Head to Head Comparison: Crispr Theraptc (CRSP) and Editas Medicine (EDIT) – Dispatch Tribunal

Head to Head Comparison: Crispr Theraptc (CRSP) and Editas Medicine (EDIT)Dispatch TribunalCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Fra… Continue reading

2017-11-10 Michael Zand NEWS

Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia – ModernMedicine

ModernMedicineTisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaModernMedicineQuote The FDA granted regular approval to tisagenlecleucel (Kymriah, Novartis) for the treatment of ALL that is refractory or in relapse in patients up to age 25.1 … Continue reading

2017-11-09 Michael Zand NEWS

Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia – ModernMedicine

ModernMedicineTisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaModernMedicineQuote The FDA granted regular approval to tisagenlecleucel (Kymriah, Novartis) for the treatment of ALL that is refractory or in relapse in patients up to age 25.1 … Continue reading

2017-11-09 Michael Zand NEWS

Dr. Inman on Biomarkers for Immunotherapy in Bladder Cancer – OncLive

Dr. Inman on Biomarkers for Immunotherapy in Bladder CancerOncLiveBrant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center discusses biomarkers for immunotherapy in patients with bladder cancer. There are not currently good biomark… Continue reading

2017-11-09 Michael Zand NEWS

Combinations Required to Further Advance Adoptive T-Cell Therapy – OncLive

OncLiveCombinations Required to Further Advance Adoptive T-Cell TherapyOncLiveA variety of adoptive T-cell therapy strategies have shown promise in clinical trials with recent FDA approvals granted to chimeric antigen receptor (CAR)-modified T-cell the… Continue reading

2017-11-09 Michael Zand NEWS
  • 1
  • …
  • 915
  • 916
  • 917
  • 918
  • 919
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Texas A&M The Battalion

Innovative biology
Texas A&M The Battalion
The past several years have seen the rapid growth of “Do-It-Yourself” synthetic biology groups, according to the Brookings Institution’s website. The Washington, D.C. based research group has reported the rise of these group in the United States and …